Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-06-002891
Filing Date
2006-03-10
Accepted
2006-03-09 21:56:42
Documents
10
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y18270e10vk.txt 10-K 370403
2 MERGER AGREEMENT y18270exv2waw1.txt EX-2.A.1 239216
3 FIRST AMENDMENT TO MERGER AGREEMENT y18270exv2waw2.txt EX-2.A.2 13742
4 MARKETING DISTRIBUTION AND SUPPLY AGREEMENT y18270exv10waa.txt EX-10.AA 89642
5 SUBSIDIARIES OF THE REGISTRANT y18270exv21wa.txt EX-21.A 414
6 CONSENT OF DELOITTE & TOUCHE LLP y18270exv23wa.txt EX-23.A 912
7 CERIFICATION y18270exv31wa.txt EX-31.A 4297
8 CERTIFICATION y18270exv31wb.txt EX-31.B 4266
9 CERTIFICATION y18270exv32wa.txt EX-32.A 1535
10 CERTIFICATION y18270exv32wb.txt EX-32.B 1522
  Complete submission text file 0000950123-06-002891.txt   727471
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Filer) CIK: 0000879993 (see all company filings)

EIN.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31533 | Film No.: 06677453
SIC: 2834 Pharmaceutical Preparations